Neptazane (Methazolamide)

What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.

Coming Soon – Save up to 85%

Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.

Prescription Required

  • Product Details

    Description

    Your eye doctor may prescribe Neptazane to treat glaucoma, a condition involving increased eye pressure that can lead to vision loss. Glaucoma often affects older adults and can cause symptoms like eye pain, headaches, halos around lights, decreased vision, nausea, and vomiting.

    Methazolamide, the active ingredient in Neptazane, is a carbonic anhydrase inhibitor that reduces the production of aqueous humor (the fluid in the eye), lowering intraocular pressure.

    Fact Table

    Formula

    C5H8N2O3S2

    License

    US FDA

    Bioavailability

    ~100%

    Legal status

    Prescription only (?)

    Chemical Name

    N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2-yl]acetamide

    Elimination half-life

    14 hours

    Dosage (Strength)

    25 mg, 50 mg tablets

    Pregnancy

    Not recommended

    Brands

    Neptazane

    Protein binding

    ~55%

    PubChem CID

    4068

    MedlinePlus

    a682091

    ChEBI

    CHEBI:6796

    ATC code

    S01EC02

    DrugBank

    DB00812

    KEGG

    D02388

    Routes of administration

    Oral

    Directions

    The usual dosage of Neptazane is 50-100 mg by mouth 2-3 times daily with or without food.

    Ingredients

    The active ingredient in Neptazane is methazolamide.

    Interactions

    Tell your doctor and pharmacist if you are taking any of the following drugs:

    • Aspirin
    • Levoketoconazole
    • Memantine
    • Metformin
    • Methotrexate
    • Topiramate

    Cautions

    Before starting Neptazane, tell your doctor about any history of kidney or liver disease, electrolyte imbalances, or blood disorders.

    Your healthcare team should regularly monitor blood electrolytes and kidney function, as methazolamide can cause significant electrolyte disturbances.

    Methazolamide can also increase the risk of metabolic acidosis, especially in diabetic patients. Symptoms such as confusion, rapid heartbeat, fatigue, or rapid breathing require immediate medical attention.

    Severe reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported with sulfonamide use, though they are rare. If suspected, discontinue use immediately.

    Severe hematologic reactions have also been reported, including agranulocytosis and aplastic anemia.

    Methazolamide can cause severe liver reactions, including fulminant hepatic necrosis. Hepatic coma may occur in patients with cirrhosis or hepatic insufficiency.

    Hypersensitivity reactions may recur with sulfonamide administration.

    Patients with pulmonary conditions like emphysema may experience aggravated acidosis.

    Side Effects

    Common adverse reactions to Neptazane can include:

    • Agranulocytosis
    • Aplastic anemia
    • Confusion
    • Diarrhea
    • Disorder of taste
    • Electrolyte imbalance
    • Fatigue
    • Fulminant liver failure
    • Hepatic necrosis
    • Loss of appetite
    • Malaise
    • Metabolic acidosis
    • Myopia
    • Nausea
    • Neutropenia
    • Paresthesia
    • Polyuria
    • Pure red cell aplasia
    • Somnolence
    • Stevens-Johnson syndrome
    • Thrombocytopenia
    • Tinnitus
    • Toxic epidermal necrolysis
    • Vomiting

    References

    Methazolamide [package insert]. Vaughan, Ontario: AA Pharma; July 2010.



    IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

    Product Code : 5365

  • Product Reviews

Processing..

Please wait while the page is loading. Do not hit refresh or the browser back button to avoid any loss of information.

If you have any questions or concerns, please contact our Customer Service team via the chat option on our website or calling us toll free at: 1-800-891-0844